The DOI matches its Crossref record.
New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin
Abstract
The metabolism of the storage polysaccharide glycogen is intimately linked with insulin action and blood glucose homeostasis. Insulin activates both glucose transport and glycogen synthase in skeletal muscle. The central issue of a long-standing debate is which of these two effects determines the rate of glycogen synthesis in response to insulin. Recent studies with transgenic animals indicate that, under appropriate conditions, each process can contribute to determining the extent of glycogen accumulation. Insulin causes stable activation of glycogen synthase by promoting dephosphorylation of multiple sites in the enzyme. A model linking this action to the mitogen-activated protein kinase signaling pathway via the phosphorylation of the regulatory subunit of glycogen synthase phosphatase gained widespread acceptance. However, the most recent evidence argues strongly against this mechanism. A newer model, in which insulin inactivates the enzyme glycogen synthase kinase-3 via the protein kinase B pathway, has emerged. Though promising, this model still does not completely explain the molecular basis for the insulin-mediated activation of glycogen synthase, which remains one of the many unknowns of insulin action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GSK-3 phosphorylates these sites, which are the most important for regulation of glycogen synthase activity [11]”
Citations
Cited by
Sorted by citations
Items 101–200 of 295
Brady, M., Kartha, P. M., Aysola, A. A., & Saltiel, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27497 · Cited by 57
Dib, K., Whitehead, J. P., Humphreys, P. J., Soos, M. A., Baynes, K., Kumar, S., Harvey, T., & O’Rahilly, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119884 · Cited by 56
“In this regard, it should be pointed out that although the signaling pathways to glucose transport and glycogen synthesis are similar, they are not thought to be identical (31).”
BackgroundGenetic engineering in mice: impact on insulin signalling and action
Lamothe, B., Baudry, A., Desbois, P., Lamotte, L., Bucchini, D., MEYTS, P. D., & Joshi, R. L. (1998) · Biochemical Journal · doi:10.1042/bj3350193 · Cited by 57
Daugaard, J. R., & Richter, E. A. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1195-8 · Cited by 56
“The mechanism by which insulin activates GS is not known in detail but is thought to involve deactivation of the enzyme glycogen synthase kinase-3 (GSK-3) via the protein kinase B pathway [ 14 ].”
BackgroundLai, Y., Liu, Y., Jacobs, R., & Rider, M. H. (2012) · Biochemical Journal · doi:10.1042/bj20120772 · Cited by 57
Tiley, H. A., Geor, R. J., & McCutcheon, L. J. (2008) · American Journal of Veterinary Research · doi:10.2460/ajvr.69.1.51 · Cited by 55
Kuma, Y., Campbell, D. G., & Cuenda, A. (2004) · Biochemical Journal · doi:10.1042/bj20031559 · Cited by 55
Franch, J., Aslesen, R., & Jensen, J. (1999) · Biochemical Journal · doi:10.1042/bj3440231 · Cited by 54
A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome
Lee, E.-J., Oh, B., Lee, J., Kimm, K., Lee, S., & Baek, K. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.026 · Cited by 54
Liu, J., & Brautigan, D. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003843200 · Cited by 53
Park, S., Kim, H., & Kim, S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00741-9 · Cited by 53
Regulation of Glycogen Metabolism
Roach, P. J., Skurat, A. V., & Harris, R. A. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070219 · Cited by 56
“There has been renewed discussion of which steps in the conversion of glucose to glycogen contribute most to determining the rate of synthesis, particularly in skeletal muscle (189, 190,325,326).”
Self-citationMcArdle Disease: A Unique Study Model in Sports Medicine
Santalla, A., Nogales‐Gadea, G., Ørtenblad, N., Brull, A., de Luna, N., Pinós, T., & Lucía, A. (2014) · Sports Medicine · doi:10.1007/s40279-014-0223-5 · Cited by 51
Metabolic Reserve of the Heart: The Forgotten Link Between Contraction and Coronary Flow
Kassiotis, C., Rajabi, M., & Taegtmeyer, H. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.11.005 · Cited by 53
“As already discussed, the inactivation of GSK-3β also leads to increased glycogen synthesis.(80) Thus, the GSK-3β pathway regulates both cardiac glycogen metabolism and cardiac growth.”
BackgroundOu, H., Yan, L., Mustafi, D., Makinen, M. W., & Brady, M. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0037-x · Cited by 52
Fournier, P. A., Bräu, L., Ferreira, L. D. M. C.-B., Fairchild, T., Raja, G., James, A., & Palmer, T. N. (2002) · Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology · doi:10.1016/s1095-6433(02)00254-4 · Cited by 51
Ciaraldi, T. P., Carter, L., Nikoulina, S. E., Mudaliar, S. R. D., McClain, D. A., & Henry, R. R. (1999) · Endocrinology · doi:10.1210/endo.140.9.6974 · Cited by 51
Vind, B. F., Birk, J. B., Vienberg, S. G., Andersen, B., Beck‐Nielsen, H., Wojtaszewski, J. F. P., & Højlund, K. (2012) · Diabetologia · doi:10.1007/s00125-012-2482-8 · Cited by 52
“Moreover, these sites are to a major extent regulated by GSK-3 during insulin stimulation [22, 25], and in none of our studies was any evidence found that the ability of insulin to inhibit GSK-3 is compromised in skeletal muscle of type 2 diabetic patients.”
BackgroundInfluentialFocal Adhesion Kinase (FAK) Regulates Insulin-stimulated Glycogen Synthesis in Hepatocytes
Huang, D., Cheung, A. T., Parsons, J. T., & Bryer‐Ash, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104252200 · Cited by 52
Lai, Y., Stuenæs, J. T., Kuo, C., & Jensen, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2007 · Cited by 48
“GS Ser645,649,653,657, Ser641, and Ser7 phosphorylation was lower in rested LG than in NG.”
BackgroundInfluentialLai, Y., Zarrinpashneh, E., & Jensen, J. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00401.2009 · Cited by 52
“Regulation of GS activity is complicated, involving covalent phosphorylation at multiple sites and allosteric activation by glucose-6-phosphate (13, 30, 41).”
BackgroundRegulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood–Brain Barrier
Ito, S., Yanai, M., Yamaguchi, S., Couraud, P., & Ohtsuki, S. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.036 · Cited by 49
Aschenbach, W. G., Ho, R. C., Sakamoto, K., FUJII, N. L., Li, Y., Kim, Y., Hirshman, M. F., & Goodyear, L. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00180.2005 · Cited by 46
“On the basis of studies where insulin was used, the primary function of GSK-3 in skeletal muscle is thought to be the regulation of glycogen metabolism via phosphorylation and deactivation of glycogen synthase (16).”
BackgroundBrain Glycogen Structure and Its Associated Proteins: Past, Present and Future
Brewer, M. K., & Gentry, M. S. (2019) · Advances in neurobiology · doi:10.1007/978-3-030-27480-1_2 · Cited by 46
Glycogen in the heart?an expanded view
Taegtmeyer, H. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.001 · Cited by 46
Abdel-Sattar, E. A., Harraz, F. M. H., Ghareib, S. A., Elberry, A. A., Gabr, S. A., & Suliaman, M. I. (2011) · Natural Product Research · doi:10.1080/14786419.2010.490782 · Cited by 43
“Increase in the secretion of insulin was found to increase the hepatic glycogen content, hexokinase activity and reduce glucose-6-phosphatase activity (Bouche, Serdy, Kahn, & Goldfine, 2004 ; Lawrence & Roach, 1997 ; van Schaftingen & Gerin, 2002 ).”
BackgroundGreenberg, C. C., Meredith, K. N., Yan, L., & Brady, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303846200 · Cited by 44
Prolonged fasting-induced metabolic signatures in human skeletal muscle of lean and obese men
Bak, A. M., Vendelbo, M. H., Christensen, B., Viggers, R., Bibby, B. M., Rungby, J., Jørgensen, J. O. L., Møller, N., & Jessen, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200817 · Cited by 42
Patel, S., MacAulay, K., & Woodgett, J. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015845 · Cited by 43
“GS is dephosphorylated and activated in response to an insulin signal in muscle and to a glucose-signal in the liver”
Oriente, F., Formisano, P., Miele, C., Fiory, F., Maitan, M. A., Vigliottá, G., Trencia, A., Santopietro, S., Caruso, M., OBBERGHEN, E. V., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104405200 · Cited by 40
GSK-3β and control of glucose metabolism and insulin action in human skeletal muscle
Ciaraldi, T. P., Carter, L., Mudaliar, S. R. D., & Henry, R. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.05.020 · Cited by 40
REGULATION OF ENERGY METABOLISM
Brody, T. (1999) · Elsevier eBooks · doi:10.1016/b978-012134836-6/50007-x · Cited by 43
A Novel Radiotracer to Image Glycogen Metabolism in Tumors by Positron Emission Tomography
Witney, T. H., Carroll, L. S., Alam, I. S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2768 · Cited by 40
Relative insensitivity of avian skeletal muscle glycogen to nutritive status1,2
Edwards, M. R., McMurtry, J. P., & VASILATOS-YOUNKEN, R. (1999) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(99)00013-2 · Cited by 40
Jensen, J., Ruzzin, J., Jebens, E., Brennesvik, E. O., & Knardahl, S. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01437.x · Cited by 39
Exercise training‐induced adaptations associated with increases in skeletal muscle glycogen content
Manabe, Y., Gollisch, K. S. C., Holton, L., Kim, Y., Brandauer, J., FUJII, N. L., Hirshman, M. F., & Goodyear, L. J. (2012) · FEBS Journal · doi:10.1111/febs.12085 · Cited by 39
Glintborg, D., Højlund, K., Andersen, N. R., Hansen, B. F., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0760 · Cited by 37
“This emphasizes that GS activity and phosphorylation is regulated by other means than insulin-mediated inhibition of GSK-3 (4, 12 , 13, 15).”
BackgroundInfluentialKalloo-Hosein, H. E., Whitehead, J. P., Soos, M. A., Tavaré, J. M., Siddle, K., & O’Rahilly, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24325 · Cited by 37
Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis
Ruan, Y., Ma, J., & Xie, X. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0387 · Cited by 36
Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes
Højlund, K., Poulsen, M. K., Stæhr, P., Brusgaard, K., & Beck‐Nielsen, H. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01098.x · Cited by 37
Liu, Z., Wu, Y., Nicklas, E. W., Jahn, L. A., Price, W. J., & Barrett, E. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00146.2003 · Cited by 36
“Insulin enhances glucose uptake, glycolysis, and glycogen synthesis in skeletal muscle, at least in part, through the activation of the phosphatidylinositol 3-kinase (PI 3-kinase)-PKB (or Akt)GSK-3 signaling pathway (7, 12, 15, 20, 25, 44).”
BackgroundInfluentialQian, Y., Bolin, D., Conde‐Knape, K., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.049 · Cited by 35
Molecular targets of lithium action
Corbella, B., & Vieta, E. (2003) · Acta Neuropsychiatrica · doi:10.1046/j.1601-5215.2003.00049.x · Cited by 35
“As mentioned, GSK3b was described as an inhibitor of glycogen synthase, which is regulated by the insulin signaling pathway (242,243,264,265).”
BackgroundMounier, C., Lavoie, L., Dumas, V., Mohammad-Ali, K., Wu, J., Nantel, A., Bergeron, J. J. M., Thomas, D. Y., & Posner, B. I. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00439-1 · Cited by 33
“GSK-3 is a serine:threonine protein kinase which inhibits GS by phosphorylation ( Lawrence and Roach, 1997 ) and is considered to be a major regulator of GS in several cell types including liver cells (Pugazhenthi and Khandelwal, 1995).”
BackgroundRole of Glycogen Synthase Kinase-3α in Insulin Action in Cultured Human Skeletal Muscle Cells
Ciaraldi, T. P., Nikoulina, S. E., Bandukwala, R., Carter, L., & Henry, R. R. (2007) · Endocrinology · doi:10.1210/en.2006-0932 · Cited by 34
Stretton, C., Evans, A., & Hundal, H. S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2010 · Cited by 33
“Phosphorylation of GSK3 results in its inactivation, which permits the stimulation of glycogen synthase, thereby facilitating storage of glucose as glycogen (18).”
BackgroundDesbois‐Mouthon, C., Eggelpoël, M.-J. B.-V., Auclair, M., Cherqui, G., Capeau, J., & Caron, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8181 · Cited by 33
Bavarva, J. H., & Narasimhacharya, A. V. R. L. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.042 · Cited by 30
Cuncic, C., Desmarais, S., Detich, N., Tracey, A., Gresser, M. J., & Ramachandran, C. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00284-1 · Cited by 30
Mechanisms of action of brain insulin against neurodegenerative diseases
Ramalingam, M., & Kim, S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1147-1 · Cited by 30
Haddad, P. S., Musallam, L., Martineau, L. C., Harris, C. S., Lavoie, L., Arnason, J. T., Foster, B., Bennett, S. A. L., Johns, T., Cuerrier, A., et al. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/893426 · Cited by 34
“Stimulation of glycogen synthesis from glucose is another way to reduce hepatic glucose production [81].”
BackgroundToole, B. J., & Cohen, P. T. W. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.11.013 · Cited by 32
Haugaard, S. B., Andersen, O., Madsbad, S., Frøsig, C., Iversen, J., Nielsen, J. O., & Wojtaszewski, J. F. P. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3474 · Cited by 29
“Because phosphorylation of the glycogen synthase NH2-terminal sites 2 2a and the COOH-terminal sites 3a and 3a b have been shown to be essential for glycogen synthase activity (28,33), we investigated basal and insulin-induced phosphorylation of these sites.”
BackgroundResultLiu, J., & Brautigan, D. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909303199 · Cited by 29
Napoli, R., Gibson, L. E., Hirshman, M. F., Boppart, M. D., Dufresne, S. D., Horton, E. S., & Goodyear, L. J. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1549 · Cited by 29
Saleem, T. S. M., & Kumar, R. P. (2010) · Journal of Experimental Pharmacology · doi:10.2147/jep.s8947 · Cited by 28
“An increase in hepatic glycogen content in Asystasia gangetica and Morus indica administered animals suggests that the activation of glycogen synthase for which the substrate glucose-6phosphate could have been readily provided by increased hexokinase activity.(30,31) These observations clearly indicate the potential o…”
Schafer, J. R. A., Fell, D. A., Rothman, D. L., & Shulman, R. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307299101 · Cited by 29
Lindegaard, B., Frøsig, C., Petersen, A. M. W., Plomgaard, P., Ditlevsen, S., Mittendorfer, B., van Hall, G., Wojtaszewski, J. F. P., & Pedersen, B. K. (2007) · Diabetes · doi:10.2337/db07-0144 · Cited by 27
“GSK-3 is a serine/threonine kinase that inhibits GS activity by phosphorylation of GS (50) at sites 4, 3c, 3b, and 3a (51).”
BackgroundPoulsen, P., Wojtaszewski, J. F. P., Petersen, I., Christensen, K., Richter, E. A., Beck‐Nielsen, H., & Vaag, A. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1289 · Cited by 28
Chaudhry, S., Bernardes, M., Harris, P. E., & Maffei, A. (2016) · PubMed · Cited by 27
Wang, H.-M., Mehta, S., Bansode, R. R., Huang, W., & Mehta, K. D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.028 · Cited by 27
Baumann, C. A., Brady, M., & Saltiel, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000856200 · Cited by 25
Expression of Constitutively Activated Giα2 in Vivo Ameliorates Streptozotocin-induced Diabetes
Zheng, X., Guo, J., Wang, H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23649 · Cited by 25
Maegawa, H., Shi, K., Hidaka, H., Iwai, N., Nishio, Y., Egawa, K., Kojima, H., Haneda, M., Yasuda, H., Nakamura, Y., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1469 · Cited by 23
Jensen, J., Aslesen, R., Jebens, E., & Skrondal, A. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00122-1 · Cited by 24
Zeng, W., Qi, W., Mu, J., Yi, W., Yang, L.-L., Zhang, Q., Wu, Q., Tang, J., & Feng, B. (2019) · Scientific Reports · doi:10.1038/s41598-018-38425-2 · Cited by 24
Højlund, K., Wojtaszewski, J. F. P., Birk, J. B., Hansen, B. F., Vestergaard, H., & Beck‐Nielsen, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0312-6 · Cited by 24
“This suggests the possibility of increased phosphorylation at site 3a alone or at sites believed to be less important for glycogen synthase activity, such as sites 1a, 1b, 3c, 4 and 5 [8, 9].”
BackgroundKasangana, P. B., Eid, H. M., Nachar, A., Stevanovic, T., & Haddad, P. S. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112167 · Cited by 23
Tsao, J.-P., Bernard, J. R., Hsu, H.-C., Hsu, C., Liao, S.-F., & Cheng, I.-S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.875319 · Cited by 27
Teixeira, S. D. S., Panveloski-Costa, A. C., Carvalho, A., Schiavon, F. P. M., Marques, A. D. C. R., Campello, R. S., Bazotte, R. B., & Nunes, M. T. (2016) · Physiological Reports · doi:10.14814/phy2.12961 · Cited by 23
“Active GSK-3 phosphorylates glycogen synthase (GS) and negatively regulates its activity, decreasing glycogen synthesis (Sutherland et al. 1993; Lawrence and Roach 1997).”
BackgroundMethodSingh, L. P., Gennerette, D., Simmons, S. T., & Crook, E. D. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00140-9 · Cited by 23
Choi, W. S. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00068-4 · Cited by 23
Hansen, L., Reneland, R., Berglund, L., Rasmussen, S. K., Hansen, T., Lithell, H., & Pedersen, O. (2000) · Diabetes · doi:10.2337/diabetes.49.2.298 · Cited by 22
A Transcriptomic Approach to Search for Novel Phenotypic Regulators in McArdle Disease
Nogales‐Gadea, G., García‐Consuegra, I., Rubio‐Terres, C., Arenas, J., Cuadros, M., Cámara, Y., Torres‐Torronteras, J., Fiuza‐Luces, C., Lucía, A., Martín, M. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031718 · Cited by 22
“GS has 9 residues that can be phosphorylated, causing progressive inactivation of the enzyme [21].”
Kasangana, P. B., Nachar, A., Eid, H. M., Stevanovic, T., & Haddad, P. S. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.017 · Cited by 22
Structure and Regulation of Glycogen Synthase in the Brain
Pederson, B. A. (2019) · Advances in neurobiology · doi:10.1007/978-3-030-27480-1_3 · Cited by 22
Lingohr, M. K. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.178 · Cited by 22
Yang, G., Zhang, Q., Dong, C., Hou, G., Li, J., Meng, L., Xin, Y., & Xin, Y. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31149 · Cited by 24
“In addition, activation of GSK ‐ 3 β can reduce the ability of cells to synthesize and store glycogen (Lawrence & Roach, 1997) and promotes involvement in the pathogenesis of cardiac hypertrophy (Rana et al., 2019).”
BackgroundCatestatin induces glycogenesis by stimulating the phosphoinositide 3‐kinase‐AKT pathway
Bandyopadhyay, G. K., Tang, K., Webster, N. J. G., van den Bogaart, G., & Mahata, S. K. (2022) · Acta Physiologica · doi:10.1111/apha.13775 · Cited by 22
Friedrichsen, M. H., Birk, J. B., Richter, E. A., Ribel‐Madsen, R., Pehmøller, C. K., Hansen, B. F., Beck‐Nielsen, H., Hirshman, M. F., Goodyear, L. J., Vaag, A. A., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00494.2012 · Cited by 22
Spatial Compartmentalization in the Regulation of Glucose Metabolism by Insulin
Brady, M., Pessin, J. E., & Saltiel, A. R. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00201-5 · Cited by 21
The insulin receptor and metabolic signaling
Gustafson, T. A., Moodie, S. A., & Lavan, B. E. (1999) · Springer eBooks · doi:10.1007/3-540-65362-7_5 · Cited by 21
Ying, Z., Zhang, H., Su, W., Zhou, L., Wang, F., Li, Y., Zhang, L., & Wang, T. (2017) · Journal of Nutrition · doi:10.3945/jn.117.253427 · Cited by 25
Kim, J. J., Park, B., Kido, Y., & Accili, D. (2001) · Endocrinology · doi:10.1210/endo.142.8.8332 · Cited by 21
Smith, J. L., Ju, J.-S., Saha, B. M., Racette, B. A., & Fisher, J. S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01219.2003 · Cited by 20
“GS, the rate-limiting enzyme for the storage of intracellular glucose as glycogen in skeletal muscle (25), is activated in the presence of insulin and inhibited by agents that increase intracellular cAMP concentrations ([cAMP]) (7, 25, 38).”
BackgroundSpecific Desensitization of Glycogen Synthase Activation by Insulin in 3T3-L1 Adipocytes
Jensen, T. C., Crosson, S. M., Kartha, P. M., & Brady, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004902200 · Cited by 20
Cortisol, but not intranasal insulin, affects the central processing of visual food cues
de Sá, D. S. F., Schulz, A., Streit, F., Turner, J. D., Oitzl, M. S., Blumenthal, T. D., & Schächinger, H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.006 · Cited by 19
Lingohr, M. K. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.2.508 · Cited by 19
“The principal signaling pathway by which insulin stimulates glycogen synthase is via activation of the insulin receptor (IR), leading to phosphatidylinositol-3 kinase (PI3K)-dependent activation of protein kinase B (PKB/ Akt), inactivation of glycogen synthase kinase-3 (GSK-3), and increased activity of glycogen synth…”
BackgroundInhibitor-1 Is Not Required for the Activation of Glycogen Synthase by Insulin in Skeletal Muscle
Scrimgeour, A. G., Allen, P. B., Fienberg, A. A., Greengard, P., & Lawrence, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20949 · Cited by 19
Self-citationTissue glycogen content and glucose intolerance
Kasuga, M., Ogawa, W., & Ohara, T. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18526 · Cited by 20
“Among the protein kinases, glycogen synthase kinase–3 (GSK-3) is thought to be an important target for insulin in its stimulation of glycogen synthase activity (5, 6).”
BackgroundHuang, L. C., Heimark, D. B., Linko, J., Nolan, R. D., & Larner, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0111 · Cited by 18
Imanaka, T., Hayashi, H., Kishi, K., Wang, L., Ishii, K., Hazeki, O., Katada, T., & Ebina, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25347 · Cited by 17
Changes in cytosolic glucose level in ATP stimulated live astrocytes
Prebil, M., Chowdhury, H. H., Zorec, R., & Kreft, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.035 · Cited by 18
Bhagavan, N. V. (2002) · Elsevier eBooks · doi:10.1016/b978-012095440-7/50017-2 · Cited by 17
Kasangana, P. B., Haddad, P. S., Eid, H. M., Nachar, A., & Kasangana, P. B. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b00079 · Cited by 17
Lai, Y., Lin, F. ‐., & Jensen, J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01998.x · Cited by 17
“GS incorporates the glucose molecules into the glycogen particle and GS represents a potential rate-limiting step during insulin-stimulated glycogen synthesis and during glycogen re-synthesis after exercise (Cohen 1993, Lawrence & Roach 1997, Wojtaszewski et al. 2002, Nielsen & Richter 2003).”
BackgroundSingh, L. P., & Crook, E. D. (2000) · Journal of Investigative Medicine · doi:10.1177/108155890004800406 · Cited by 17
Limonia fruit as a food supplement to regulate fluoride‐induced hyperglycaemia and hyperlipidaemia
Vasant, R. A., & Narasimhacharya, A. V. R. L. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.5762 · Cited by 16
Role of glycogen content in insulin resistance in human muscle cells
Litherland, G. J., Morris, N. J., Walker, M., & Yeaman, S. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20942 · Cited by 16
Ortmeyer, H. K. (2001) · Journal of Nutrition · doi:10.1093/jn/131.3.907s · Cited by 16
Metadata
- Authors
- Lawrence, J. C., & Roach, P. J.
- Affiliations
- University of Virginia (US)
- Indiana University Indianapolis (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-04-01
- Volume
- 46
- Issue
- 4
- Pages
- 541-547
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2140664543
- Cited by
- 311
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 3 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 4 · 2014: 10 · 2013: 3 · 2012: 14
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1zicar041189-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK28312, DK 27221, R01DK028312)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR41189)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- glycogen synthase, insulin signaling, glycogen synthesis, glycogen synthase kinase-3, Akt, mitogen-activated protein kinase, glycogen synthase phosphatase, glucose transport, skeletal muscle, blood glucose homeostasis
- MeSH terms
- Animals, Enzyme Activation, Glycogen, Glycogen Synthase, Humans, Insulin, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review